https://www.templehealth.org/about/news/fox-chase-researchers-find-ripretinib-significantly-improves-survival-for-patients-with-advanced-gastrointestinal-tumors
Researchers at Fox Chase Cancer Center recently published the results of an international study showing improved survival for patients with advanced gastrointestinal stromal tumors who used ripretinib (Qinlock) when compared with patients taking a placebo.